Evaluating Intravenous Dexamethasones Effect on Spinal Anesthesia Duration Using Hyperbaric Bupivacaine in Lower Abdominal Surgery
Led by Holy Family Hospital, Pakistan · Updated on 2026-09-15
110
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effect of intravenous dexamethasone on the duration of spinal anesthesia using hyperbaric bupivacaine in adults undergoing lower abdominal surgery. The study aims to understand whether dexamethasone can prolong the sensory and motor block during spinal anesthesia, which is important for improving pain management during and after surgery. Eligible patients are classified as ASA physical status I or II and are undergoing elective lower abdominal or orthopedic surgeries.
Participants will receive either 8 mg of dexamethasone diluted in 100 mL normal saline or 100 mL normal saline alone through a peripheral intravenous cannula about 10 minutes before spinal anesthesia. Spinal anesthesia will be administered with 12-15 mg of 0.75% hyperbaric bupivacaine using a 25-gauge spinal needle at the lower lumbar region. The sensory and motor block levels will be assessed regularly to monitor anesthesia effectiveness and regression.
During the study, participants will undergo sensory and motor assessments at 15-minute intervals after spinal anesthesia administration until the sensory block regresses to the lower thoracic levels. Postoperative pain will be measured using a visual pain scale four hours after surgery. Researchers will collect patient information including age, sex, diagnosis, surgery type, and durations of sensory and motor block to analyze the impact of dexamethasone. The primary outcomes are time to sensory block regression and time until rescue analgesia is requested, both monitored for up to six hours after anesthesia.
CONDITIONS
Brief Title
Dexamethasone and Duration of Spinal Anesthesia
Research Team
T
Tayyab Principal Investigator, MBBS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patients undergoing lower abdominal and orthopedic surgeries including pelvic and lower extremity surgeries
Classified as American Society of Anesthesiologists (ASA) physical status I or II
Adults aged 20 to 40 years
You will not qualify if you...
History of spinal surgery, spinal instrumentation, or previous failed spinal anesthesia
Pre-existing neurological disorders, peripheral neuropathy, or sensory/motor deficits
Known allergy to local anesthetics or dexamethasone
Congenital spinal deformities or acquired spinal conditions like advanced spondylosis or kyphoscoliosis
Contraindications to spinal anesthesia such as coagulopathy, local infection at injection site, or raised intracranial pressure
Diabetes mellitus, chronic steroid therapy, immunosuppression, or systemic infection
Pregnant patients or those undergoing emergency surgeries
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Up to 6 hours after spinal anesthesia
Participants receive either intravenous dexamethasone or saline placebo before spinal anesthesia, followed by administration of spinal anesthesia with hyperbaric bupivacaine. Sensory and motor block levels are regularly assessed during surgery.
Assessments every 15 minutes during surgery and recovery
Follow-up
Duration - 4 hours after surgery
Postoperative monitoring includes continued assessment of sensory and motor block and evaluation of pain using a visual pain scale at 4 hours after surgery.
1 visit in Post-Anesthesia Care Unit
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Similar Trials
Randomized Study of Zipalertinib Versus Placebo in Early Stage Non-Small Cell Lung Cancer With Uncommon EGFR Mutations After Complete Tumor Removal
Phase III Study of Adjuvant Transarterial Chemoembolization After Curative Surgery in Hepatocellular Carcinoma Patients with High-Risk Recurrence Factors
Adjuvant Chemotherapy and Immunotherapy After Surgery for Esophageal and Esophageal-Gastric Junction Cancer With High Risk of Recurrence
Safety Evaluation of Intraparotid Injection of Bupivacaine with Dexamethasone During Partial Parotidectomy for Benign Tumors A Prospective Single-Center Study
Evaluating Intravenous Dexamethasones Effect on Spinal Anesthesia Duration Using Hyperbaric Bupivacaine in Lower Abdominal Surgery
Study of Intravenous Dexamethasone to Extend Spinal Anesthesia Duration in Pregnant Women Undergoing Cesarean Section
Comparing Dexamethasone and Magnesium Sulphate Added to Bupivacaine for Postoperative Pain Relief After Elective Cesarean Section with Spinal Anesthesia
Study of Dexamethasone, Dexmedetomidine, and Their Combination
on Postoperative Gastrointestinal Function
After Elective Laparoscopic Gallbladder Surgery
Comparing Dexmedetomidine Plus Bupivacaine Versus Bupivacaine Alone for Pain Relief After Craniotomy Surgery
Comparing Dexmedetomidine, Ozone, and Dexamethasone Injections for Long-Term Pain Relief in Carpal Tunnel Syndrome
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Effect of intravenous dexamethasone on the duration of hyperbaric bupivacaine spinal anesthesia in lower abdominal surgery, Randomized controlled trial.
Amani H Abdel-Wahab, Essam S Abd Alla, Taghreed Abd El-Azeem